Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
593600
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the First Series Stock Acquisition Rights with Exercise Price Adjustment Clauses issued through a third-party allotment
発行・処分する株式数593,600Shares
Shares delivered during the month: 593,600 shares (new shares)
Intended allottee
Apricus Partners合同会社 (allottee subject to the exercise status report)
発行済株式総数
Exercise ratio subject to exercise restrictions: 4.37% (593,600 shares / 13,585,521 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month: ¥1,065, ¥1,107, ¥1,160, ¥1,232, ¥1,169, ¥1,142, ¥1,163, ¥1,188, ¥1,187, ¥1,244, ¥1,260, ¥1,229, ¥1,196, ¥1,087, ¥1,084 and ¥1,075. Details of the adjustment clauses and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total issued: 35,000; exercised during the month: 5,936; unexercised at the end of the preceding month: 33,120; unexercised at month-end: 27,184
Procedures under the Corporate Code of Conduct
As the status of compliance with exercise restrictions, the disclosure states that the exercise restrictions under Article 434 of the Listing Regulations were observed.
Most recent equity financing
Timing 16 March 2026 / Type Issuance of the First Series Stock Acquisition Rights with Exercise Price Adjustment Clauses through a third-party allotment / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the First Series Stock Acquisition Rights with Exercise Price Adjustment Clauses issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month: 593,600 shares (new shares) |
| Intended allottee | Apricus Partners合同会社 (allottee subject to the exercise status report) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 4.37% (593,600 shares / 13,585,521 shares) |
| Total number of issued shares | 13,773,521 shares (as of the end of the month preceding the subject month, including 7,837 treasury shares) → Not disclosed |
| Exercise price | Exercise prices during the month: ¥1,065, ¥1,107, ¥1,160, ¥1,232, ¥1,169, ¥1,142, ¥1,163, ¥1,188, ¥1,187, ¥1,244, ¥1,260, ¥1,229, ¥1,196, ¥1,087, ¥1,084 and ¥1,075. Details of the adjustment clauses and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 35,000; exercised during the month: 5,936; unexercised at the end of the preceding month: 33,120; unexercised at month-end: 27,184 |
| Procedures under the Corporate Code of Conduct | As the status of compliance with exercise restrictions, the disclosure states that the exercise restrictions under Article 434 of the Listing Regulations were observed. |
| Most recent equity financing | Timing 16 March 2026 / Type Issuance of the First Series Stock Acquisition Rights with Exercise Price Adjustment Clauses through a third-party allotment / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on the monthly exercise status, and no reason for exercise is stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.